P. Lupien

发表

Genetic aspects of susceptibility to obesity and related dyslipidemias

C. Bouchard, J. Després, A. Tremblay, 1992, Molecular and Cellular Biochemistry.

Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia.

M. Vohl, P. Couture, J. Bergeron, 2002, Atherosclerosis.

A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

D. Rader, B. Clark, H. Brewer, 1995, Nature Medicine.

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

J. Després, D. Gaudet, J. Simard, 1998, Arteriosclerosis, thrombosis, and vascular biology.

Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.

G. Dagenais, J. Després, A. Tchernof, 1998, JAMA.

Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

G. Dagenais, J. Després, B. Lamarche, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Leptinemia Is Not a Risk Factor for Ischemic Heart Disease in Men: Prospective results from the Quebec Cardiovascular Study

G. Dagenais, J. Després, C. Couillard, 1998, Diabetes Care.

Influence of triglyceride concentration on the relationship between lipoprotein cholesterol and apolipoprotein B and A-I levels.

G. Dagenais, J. Després, I. Lemieux, 2000, Metabolism: clinical and experimental.

Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study)

G. Dagenais, J. Després, B. Lamarche, 1995, The American journal of cardiology.

Effect of hyperchylomicronemia on the measurement of hemoglobin.

S. Moorjani, P. Lupien, C. Gagné, 1977, American journal of clinical pathology.

Effectiveness of 3-hydroxy-3-methylglutaric acid in familial hypercholesterolaemia.

S. Moorjani, P. Lupien, D. Brun, 1973, Lancet.

Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia.

S. Moorjani, P. Lupien, C. Gagné, 1986, Metabolism: clinical and experimental.

Changes in plasma lipoprotein and apolipoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women.

P. Dupont, F. Labrie, S. Moorjani, 1991, The Journal of clinical endocrinology and metabolism.

Effects of dextrothyroxine on the pituitary-thyroid axis in hypercholesterolemic children and goitrous adults.

J. Dussault, S. Moorjani, P. Coulombe, 1980, The Journal of clinical endocrinology and metabolism.

Heterozygous familial hypercholesterolemia. Relationship between plasma lipids, lipoproteins, clinical manifestations and ischaemic heart disease in men and women.

S. Moorjani, P. Lupien, C. Gagné, 1979, Atherosclerosis.

Comparison of the effect of two low‐density lipoprotein receptor class mutations on coronary heart disease among French‐Canadian patients heterozygous for familial hypercholesterolaemia

J. Després, D. Gaudet, M. Vohl, 1997, European journal of clinical investigation.

Effects of 3‐Hydroxy‐3‐methylglutaric Acid on Plasma and Low‐Density Lipoprotein Cholesterol Levels in Familial Hypercholesterolemia

P. Bielmann, S. Moorjani, P. Lupien, 1979, Journal of clinical pharmacology.

[Incidence of arterial hypertension in the Quebec region].

G. Dagenais, J. Rochon, P. Lupien, 1983, Clinical and investigative medicine. Medecine clinique et experimentale.

population:. 1. Associa tion of plasma lipid and lipoprotein levels with age, relative body weight and education 0

G. Dagenais, J. Jobin, S. Moorjani, 2005 .

Intermittent claudication in Quebec men from 1974-1986: the Quebec Cardiovascular Study.

G. Dagenais, S. Gingras, P. Lupien, 1991, Clinical and investigative medicine. Medecine clinique et experimentale.

Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.

P. Julien, S. Moorjani, P. Lupien, 1991, The Canadian journal of cardiology.

Adipose Tissue Distribution and Plasma Lipoprotein Levels in Obese Women: Importance of Intra‐abdominal Fat

C. Bouchard, J. Després, A. Tremblay, 1989, Arteriosclerosis.

Removal of Cholesterol from Blood by Affinity Binding to Heparin-Agarose: Evaluation on Treatment in Homozygous Familial Hypercholesterolemia

S. Moorjani, P. Lupien, C. Gagné, 1980, Pediatric Research.

Is body fat loss a determinant factor in the improvement of carbohydrate and lipid metabolism following aerobic exercise training in obese women

C. Bouchard, J. Després, A. Tremblay, 1992 .

Computer assisted instruction for retraining family doctors in hypertension and hyperlipoproteinemia

G. Dagenais, J. D'ivernois, P. Lupien, 1979, Medical Education.

Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group.

J. T. Clarke, M. Hayden, E. Levy, 1996, Pediatrics.

Systolic blood pressure during submaximal exercise: an important correlate of cardiovascular disease risk factors in normotensive obese women.

C. Bouchard, D. Prud'homme, A. Nadeau, 1994, Metabolism: clinical and experimental.

Lipid profile of a French-Canadian population: 1. Association of plasma lipid and lipoprotein levels with age, relative body weight and education.

G. Dagenais, S. Moorjani, J. Rochon, 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Homozygous Familial Hypercholesterolemia among French Canadians in Quebec Province

M. Lambert, J. Davignon, P. Lupien, 1989, Arteriosclerosis.

Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels

A Tremblay, C Bouchard, C. Bouchard, 1992, Diabetes.

The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.

D. Prud'homme, S. Moorjani, P. Lupien, 1996, Metabolism: clinical and experimental.

Geographic distribution of French‐Canadian low‐density lipoprotein receptor gene mutations in the Province of Quebec

J. Després, D. Gaudet, M. Vohl, 1997, Clinical genetics.

The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.

D. Rader, J. Hoeg, M. Grossman, 1995, The Journal of clinical investigation.

Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide.

F. Labrie, S. Moorjani, A. Bélanger, 1988, The Journal of clinical endocrinology and metabolism.

Mutations in the gene for lipoprotein lipase. A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia.

D. Gaudet, M. Hayden, J. Kastelein, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Extracorporeal removal of plasma lipoproteins by affinity binding to heparin-agarose.

S. Moorjani, P. Lupien, J. Awad, 1977, Clinica chimica acta; international journal of clinical chemistry.

Effects of fenfluramine in hypertriglyceridemic obese subjects.

P. Bielmann, A. Nadeau, S. Moorjani, 1988, International journal of obesity.

Smoking, alcohol consumption, lipid and lipoprotein levels.

G. Dagenais, S. Moorjani, J. Rochon, 1988, The Canadian journal of cardiology.

Influence of diets containing cow's milk or soy protein beverage on plasma lipids in children with familial hypercholesterolemia.

S. Moorjani, D. Laurin, P. Lupien, 1992, Journal of the American College of Nutrition.

Heterozygous familial hypercholesterolemia in children: low-density lipoprotein receptor mutational analysis and variation in the expression of plasma lipoprotein-lipid concentrations.

J. Després, M. Vohl, B. Lamarche, 1996, Atherosclerosis.

Rapid restriction fragment analysis for screening four point mutations of the Low‐density lipoprotein receptor gene in French Canadians

J. Després, J. Simard, M. Vohl, 1995, Human mutation.

Articular manifestations of familial hypercholesterolaemia.

S. Moorjani, P. Lupien, C. Gagné, 1985, Annals of the rheumatic diseases.

Geographic distribution and genealogy of mutation 207 of the lipoprotein lipase gene in the French Canadian population of Québec

M. Hayden, P. Julien, J. Bergeron, 1992, Human Genetics.

Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia

James M. Wilson, E. Stein, J. Engelhardt, 1994, Nature Genetics.

Risk factors for ischaemic heart disease: is it time to measure insulin?

G. Dagenais, J. Després, B. Lamarche, 1996, European heart journal.

Primary lipoprotein-lipase-activity deficiency: clinical investigation of a French Canadian population.

P. Julien, S. Moorjani, P. Lupien, 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Effect of obesity on plasma triglyceride levels in familial lipoprotein lipase deficiency

J. Després, D. Gaudet, M. Vohl, 1995 .

Dyslipidemias associated with heterozygous lipoprotein lipase mutations in the French‐Canadian population

M. Hayden, P. Julien, G. Lévesque, 1998, Human mutation.

Alterations in erythrocyte membrane lipid composition and fluidity in primary lipoprotein lipase deficiency.

P. Julien, P. Lupien, C. Gagné, 1992, Biochimica et biophysica acta.

Premature coronary artery disease and high prevalence of monogenic traits for lipid disorders among French Canadians in a North Eastern region of Quebec province

D. Gaudet, P. Julien, S. Moorjani, 1994 .

Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals.

S. Schwartz, H. Haber, S. Weiss, 1997, The American journal of cardiology.

Identification of three mutations in the low‐density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians

J. Després, D. Gaudet, J. Simard, 1998, Human mutation.

Alcohol consumption and plasma lipoproteins.

S. Moorjani, P. Lupien, 1990, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

In vitro and in vivo inhibition of hepatic cholesterol synthesis by 3-hydroxy-3-methylglutaric acid.

Z. Beg, P. Lupien, 1972, Biochimica et biophysica acta.

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

G. Dagenais, J. Després, B. Lamarche, 1996, The New England journal of medicine.

Dose‐response to tibric acid: A new hypolipidemic drug in type IV hyperlipoproteinemia

P. Bielmann, S. Moorjani, P. Lupien, 1975, Clinical pharmacology and therapeutics.

3-Hydroxy-3-methylglutaric acid: protective action in experimental atherosclerosis in rabbits.

Z. Beg, P. Lupien, M. Tremblay, 1973, Atherosclerosis.

Adipose cell size and distribution in familial lipoprotein lipase deficiency.

J. Després, P. Julien, P. Lupien, 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

917-99 Fibrinogen and Lp(a) in Ischemic Heart Disease. The Québec Cardiovascular Study

G. Dagenais, J. Després, S. Moorjani, 1995 .

Detection of a novel mutation (stop 468) in exon 10 of the low-density lipoprotein receptor gene causing familial hypercholesterolemia among French Canadians.

J. Després, J. Simard, M. Vohl, 1994, Human molecular genetics.

Effects of a soy-protein beverage on plasma lipoproteins in children with familial hypercholesterolemia.

S. Moorjani, D. Laurin, P. Lupien, 1991, The American journal of clinical nutrition.

Effect of sulfamerazine and exercise on life span of rats and hamsters.

P. Lupien, C. Mccay, G. Sperling, 1978, Gerontology.

A monoclonal antibody against human lipoprotein lipase inhibiting heparin binding without affecting catalytic activity.

Y. Deshaies, P. Julien, P. Lupien, 1996, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Triglyceride metabolism in pyridoxine-deficient rats.

P. Lupien, A. Audet, 1974, The Journal of nutrition.

Founder effect in familial hyperchylomicronemia among French Canadians of Quebec.

P. Julien, P. Lupien, C. Gagné, 1991, Human heredity.

Parabiosis as a method for studying factors which affect aging in rats.

P. Lupien, C. Mccay, G. Sperling, 1963, Gerontologia.

Total and coronary heart disease mortality in relation to major risk factors--Quebec cardiovascular study.

G. Dagenais, S. Gingras, J. Rochon, 1990, The Canadian journal of cardiology.

Hypertriglyceridemia and Lower LDL Cholesterol Concentration in Relation to Apolipoprotein E Phenotypes in Myotonic Dystrophy

J. Morissette, D. Gaudet, C. Laberge, 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

Beta blockers and their effects on lipoproteins, phospholipids, apoproteins A and B, in whole plasma and the different fractions.

P. Bielmann, P. Lupien, C. Gagné, 1982, International journal of clinical pharmacology, therapy, and toxicology.

A NEW APPROACH TO THE MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLÆMIA: REMOVAL OF PLASMA-CHOLESTEROL BASED ON THE PRINCIPLE OF AFFINITY CHROMATOGRAPHY

S. Moorjani, P. Lupien, J. Awad, 1976, The Lancet.

Ecdysone as a hypocholesterolemic agent.

P. Lupien, K. D. Chaudhary, C. Hinse, 1969, Archives internationales de physiologie et de biochimie.

Gas-liquid chromatography of mevalonic acid and β-hydroxy-β-methylglutaric acid

P. Lupien, C. Hinse, 1967 .

A method for rapid microassay of 3-hydroxy-3-methylglutaryl-CoA reductase activity.

S. Moorjani, P. Lupien, H. R. Murthy, 1978, Analytical biochemistry.

LONG-TERM TREATMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA WITH 3-HYDROXY-3-METHYLGLUTARIC ACID

S. Moorjani, P. Lupien, D. Brun, 1978, The Lancet.

Role of Deep Abdominal Fat in the Association Between Regional Adipose Tissue Distribution and Glucose Tolerance in Obese Women

C. Bouchard, J. Després, A. Tremblay, 1989, Diabetes.

Cholesterol metabolism and vitamin B6. I. Hepatic cholesterogenesis and pyridoxine deficiency.

P. Lupien, M. Avery, C. Hinse, 1969, Canadian journal of biochemistry.

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.

G. Dagenais, J. Després, A. Tchernof, 1997, Circulation.

Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study.

G. Dagenais, J. Després, B. Lamarche, 1996, Circulation.

Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.

G. Dagenais, J. Després, B. Lamarche, 1998, Journal of the American College of Cardiology.

Is Lp(a) an independent risk factor for ischemic heart disease? The Québec cardiovascular study

G. Dagenais, J. Després, S. Moorjani, 1996 .

Lipoprotein(a) distribution in a French Canadian population and its relation to intermittent claudication (the Québec Cardiovascular Study)

G. Dagenais, S. Moorjani, P. Lupien, 1995, The American journal of cardiology.

Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec cardiovascular study.

G. Dagenais, J. Després, B. Lamarche, 1996, Atherosclerosis.

Long term treatment of two familial hypercholesterolemic heterozygote patients with batch affinity chromatography (BAC).

G. Dagenais, S. Moorjani, P. Lupien, 1982, Artery.

Selective Removal of Low Density Lipoproteins from Blood by Affinity Chromatography

S. Moorjani, P. Lupien, M. Lou, 1980 .

Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).

G. Dagenais, J. Després, B. Lamarche, 2002, The American journal of cardiology.

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

A. Sorisky, T. Ooi, L. Leiter, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Heredity and Changes in Plasma Lipids and Lipoproteins after Short‐term Exercise Training in Men

C. Bouchard, J. Després, A. Tremblay, 1988, Arteriosclerosis.

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.

D. Sprecher, S. Schwartz, H. Haber, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Effects of Removing the Rumen, Reticulum, Omasum, and Proximal Third of the Abomasum on Digestion and Blood Changes in Calves

F. Sauer, P. Lupien, G. Hatina, 1962 .

The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men

J. Després, D. Prud'homme, A. Tchernof, 1996, Diabetes Care.

Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma.

F. Labrie, S. Moorjani, A. Bélanger, 1987, Metabolism: clinical and experimental.

Determination of glutamic acid decarboxylase activity in rat brain.

P. Lupien, L. Berlinguet, C. Hinse, 1968, Analytical Biochemistry.

Effects of pyridoxine deficiency and dietary cholesterol supplementation in the chick on plasma protein-bound iodine, glutamic-oxalacetic transaminase activity, and 14-C-acetate incorporation into cholesterol.

P. Lupien, 1966, Canadian journal of biochemistry.

Cholesterol metabolism and vitamin B6: II. Intestinal cholesterogenesis in vitamin B6 deficient rats

P. Lupien, M. Avery, 2006, Lipids.

Probucol and high-density-lipoprotein cholesterol.

S. Moorjani, P. Lupien, C. Gagné, 1980, Canadian Medical Association journal.

First coronary heart disease event rates in relation to major risk factors: Quebec cardiovascular study.

G. Dagenais, S. Gingras, S. Moorjani, 1990, The Canadian journal of cardiology.

Reduction of LDL-C by more than 60% with the HMG-CoA reductase inhibitor atorvastatin

D. Sprecher, S. Schwartz, H. Haber, 1994 .

Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemia.

M. Hayden, R. Hegele, J. Little, 1994, The American journal of cardiology.

Impact of systolic and diastolic blood pressure on ischemic vascular diseases in French-Canadian men from 1974 to 1990.

G. Dagenais, P. Lupien, N. Robitaille, 1994, The Canadian journal of cardiology.

EFFECT OF AN ANTIBIOTIC ON LIPID FRACTIONS IN PLASMS AND EGG YOLK OF LAYING HENS.

P. Lupien, G. Hatina, F. A. Vandenheuvel, 1963, Canadian journal of biochemistry and physiology.

Hemolysis in primary lipoprotein lipase deficiency.

P. Julien, P. Lupien, C. Gagné, 1995, Metabolism: clinical and experimental.

Effect in vitro of 3-hydroxy-3-methylglutaric acid on the synthesis of mevalonate and its precursors.

S. Moorjani, P. Lupien, 1977, Archives internationales de physiologie et de biochimie.

A hepatic lipase gene mutation associated with heritable lipolytic deficiency.

R. Hegele, J. Little, P. Connelly, 1991, The Journal of clinical endocrinology and metabolism.

Relation of Steroid Hormones to Glucose Tolerance and Plasma Insulin Levels in Men: Importance of visceral adipose tissue

J. Després, D. Prud'homme, A. Tchernof, 1995, Diabetes Care.

The response to exercise with constant energy intake in identical twins.

C. Bouchard, J. Després, A. Tremblay, 1994, Obesity research.

Influence of vitamin B-6 on the renin--angiotensin system in rats.

P. Lupien, R. Despointes, C. B. Delorme, 1975, The Journal of nutrition.

The ApoB-100 Gene EcoRI Polymorphism Influences the Relationship Between Features of the Insulin Resistance Syndrome and the Hyper-ApoB and Dense LDL Phenotype in Men

C. Bouchard, J. Després, M. Vohl, 1996, Diabetes.

ABILITY OF STARVATION AND OF DIETARY CHOLESTEROL TO SUPPRESS INCORPORATION OF LABELLED PRECURSORS INTO CHICK LIVER AND PLASMA CHOLESTEROL.

B. B. Migicovsky, P. Lupien, 1964, Canadian journal of biochemistry.

The response to long-term overfeeding in identical twins.

A Tremblay, C Bouchard, C. Bouchard, 1990, The New England journal of medicine.

Metabolic and antihypertensive effects of nebivolol and atenolol in normometabolic patients with mild-to-moderate hypertension.

D. Bichet, P. Bielmann, P. Cartier, 1999, American journal of therapeutics.

Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.

A Tremblay, C Bouchard, C. Bouchard, 1990, Arteriosclerosis.

Effect of ecdysone on glutamic decarboxylase in rat brain

P. Lupien, K. D. Chaudhary, C. Hinse, 1969, Experientia.

Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.

A Tremblay, C Bouchard, C. Bouchard, 1994, The American journal of cardiology.

The effect of vitamin B-6 deficiency on the fatty acid composition of the major phospholipids in the rat.

P. Lupien, C. B. Delorme, 1976, The Journal of nutrition.

A mutation in the human lipoprotein lipase gene as the most common cause of familial chylomicronemia in French Canadians.

M. Hayden, P. Julien, J. Brunzell, 1991, The New England journal of medicine.

Reduced testosterone and adrenal C19 steroid levels in obese men.

J. Després, D. Prud'homme, A. Tchernof, 1995, Metabolism: clinical and experimental.

Plasma high-density lipoprotein cholesterol but not apolipoprotein A-I is a good correlate of the visceral obesity-insulin resistance dyslipidemic syndrome.

C. Bouchard, J. Després, A. Tremblay, 1996, Metabolism: clinical and experimental.

Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women?

C. Bouchard, J. Després, D. Prud'homme, 1995, Metabolism: clinical and experimental.

Loss of abdominal fat and metabolic response to exercise training in obese women.

C. Bouchard, A. Tremblay, G. Thériault, 1991, The American journal of physiology.

Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia

M. Lambert, P. Lupien, S. Moorjani, 1993, The Lancet.

The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.

J. Després, D. Prud'homme, S. Lemieux, 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Assessment of adipose tissue distribution by computed axial tomography in obese women: association with body density and anthropometric measurements

C. Bouchard, J. Després, A. Tremblay, 1989, British Journal of Nutrition.

Homozygous familial hypercholesterolaemia

S. Moorjani, P. Lupien, C. Gagné, 1994, The Lancet.

Role of hepatic-triglyceride lipase activity in the association between intra-abdominal fat and plasma HDL cholesterol in obese women.

C. Bouchard, A. Tremblay, G. Thériault, 1989, Arteriosclerosis.

Metabolic heterogeneity associated with high plasma triglyceride or low HDL cholesterol levels in men.

C. Bouchard, J. Després, A. Tremblay, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Familial lipoprotein lipase-activity deficiency: study of total body fatness and subcutaneous fat tissue distribution.

C. Bouchard, P. Julien, P. Lupien, 1989, Metabolism: clinical and experimental.

A simplified procedure for the concentration, desalting, and thin-layer chromatography of mevalonic acid from reaction mixtures used to assay 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity.

S. Moorjani, P. Lupien, H. R. Murthy, 1977, Analytical biochemistry.